Evidence map›Paper›PMID 12692706›Full record

Trial reportPsychopharmacology2003

Effects of sertraline on autonomic and cognitive functions in healthy volunteers.

Martin Siepmann, Jens Grossmann, Michael Mück-Weymann, Wilhelm Kirch

Abstract readClinical TrialRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Psychopharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Event-Related Potential Markers of Suicidality in Adolescents.The international journal of neuropsychopharmacology · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Serotonin and brain function: a tale of two receptors.Journal of psychopharmacology (Oxford, England) · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Treating Chronic Pain with SSRIs: What Do We Know?Pain research & management · 2016
    Review
  17. Article
  18. Appetite loss and neurocognitive deficits in late-life depression.International journal of geriatric psychiatry · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Martin SiepmannInstitute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstrasse 27, 01307, Dresden, Germany. Martin.Siepmann@mailbox.tu-dresden.de
Jens Grossmann
Michael Mück-Weymann
Wilhelm Kirch
TU Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleThough sertraline, a selective serotonin reuptake inhibitor (SSRI), causes autonomic and cognitive adverse events such as dry mouth and somnolence, there is a paucity of appropriately designed studies on the cognitive and autonomic effects of the drug in the literature.

objectiveTo compare the effects of sertraline on cognitive and autonomic functions with those of placebo in healthy humans.

methodA randomized, double blind, cross over study of 12 healthy male volunteers aged 24 (21- 32; median; range) years. Subjects orally received 50 mg sertraline and placebo once daily for periods of 14 days each with at least 14 days in between. Heart rate variability (HRV), skin conductance level (SCL) and skin conductance response (SCR) following sudden deep respiration were employed as parameters for autonomic function. Quantitative EEG (qEEG) and psychometric tests served as parameters for cognitive function. Measurements were performed repeatedly before the start of drug administration and on the last treatment day.

resultsSertraline caused a significant reduction of heart rate and SCL ( P<0.05), whereas HRV and SCR were not changed. Cognitive functions such as flicker fusion frequency, memory, choice reaction time and psychomotor performance were not influenced by sertraline but slow and fast beta power density in the qEEG was increased.

conclusionCognitive and psychomotor performance are not altered in healthy humans receiving multiple dosing with sertraline. The observed decreases in heart rate and SCL may be due to a sympatho-inhibitory effect of sertraline.

Indexed as

AdultAutonomic Nervous SystemCognitionElectroencephalographyGalvanic Skin ResponseHeart RateHumansMalePsychometricsSelective Serotonin Reuptake InhibitorsSertralineSelective Serotonin Reuptake InhibitorsSertraline

Identifiers

PMID12692706
OpenAlexW2061666886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.